Original title: Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia
Josef Klhůfek, Martin Vodička, Martin Fajkus, Ilja Ryšavý +2 · September 2026
Some hospital patients develop hypotonic hyponatraemia, a condition where the concentration of sodium in the blood drops too low. Doctors know that a water pill called spironolactone can link to this problem. However, they did not fully understand how it shifts other blood chemicals, especially when patients also take a second water pill called furosemide. To find out, researchers studied hospital records of patients with low blood sodium who did not take thiazide water pills. They compared patients taking spironolactone against those who did not. They found that patients taking spironolactone had higher levels of potassium and urea in their blood. Even though potassium stayed higher in the blood, the kidneys did not excrete less potassium in the urine. Taking furosemide alongside spironolactone did not clearly change this specific biochemical pattern.
You are making a salad dressing and the recipe says to add a little salt. You add it, but then you taste it and it is too salty, so you add more oil expecting the saltiness to mellow. The problem is that the oil does not change the saltiness at all, so you still cannot tell how much salt is actually in there. In this paper, the recipe is the body's normal salt-and-water balance, the first addition is a medicine that affects that balance, and the oil is a second medicine that was expected to change the effect but did not.
Doctors often prescribe spironolactone for heart failure, but it can cause low sodium. This study shows the medicine also raises potassium and urea (a waste product) in the blood, and that combining it with a common water pill does not change that pattern. Knowing this helps doctors recognize the medicine as a possible cause of abnormal blood tests.
This is a single-centre retrospective cohort, so it cannot prove causation. The abstract does not list all potential confounders. It found no clear evidence that furosemide changed the pattern, but that is not proof of no effect. The diagnostic utility of the pattern was not established and needs prospective studies.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Biochemical characteristics associated with spironolactone use in hospitalized patients with hypotonic hyponatraemia — Josef Klhůfek, Martin Vodička, Martin Fajkus et al. — Annals of medicine — doi:10.1080/07853890.2026.2718576
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.